BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23996541)

  • 1. Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.
    Gao S; Li X; Amendt BA
    Curr Allergy Asthma Rep; 2013 Dec; 13(6):613-21. PubMed ID: 23996541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome.
    Gao S; Moreno M; Eliason S; Cao H; Li X; Yu W; Bidlack FB; Margolis HC; Baldini A; Amendt BA
    Hum Mol Genet; 2015 Apr; 24(8):2330-48. PubMed ID: 25556186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.
    Hasten E; McDonald-McGinn DM; Crowley TB; Zackai E; Emanuel BS; Morrow BE; Racedo SE
    Hum Mol Genet; 2018 Jun; 27(11):1847-1857. PubMed ID: 29509905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TBX1 in human del22q11.2 syndrome.
    Yagi H; Furutani Y; Hamada H; Sasaki T; Asakawa S; Minoshima S; Ichida F; Joo K; Kimura M; Imamura S; Kamatani N; Momma K; Takao A; Nakazawa M; Shimizu N; Matsuoka R
    Lancet; 2003 Oct; 362(9393):1366-73. PubMed ID: 14585638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
    Ogata T; Niihori T; Tanaka N; Kawai M; Nagashima T; Funayama R; Nakayama K; Nakashima S; Kato F; Fukami M; Aoki Y; Matsubara Y
    PLoS One; 2014; 9(3):e91598. PubMed ID: 24637876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability of atypical 22q11.2 deletions not including TBX1.
    Verhagen JM; Diderich KE; Oudesluijs G; Mancini GM; Eggink AJ; Verkleij-Hagoort AC; Groenenberg IA; Willems PJ; du Plessis FA; de Man SA; Srebniak MI; van Opstal D; Hulsman LO; van Zutven LJ; Wessels MW
    Am J Med Genet A; 2012 Oct; 158A(10):2412-20. PubMed ID: 22893440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.
    Mesbah K; Rana MS; Francou A; van Duijvenboden K; Papaioannou VE; Moorman AF; Kelly RG; Christoffels VM
    Hum Mol Genet; 2012 Mar; 21(6):1217-29. PubMed ID: 22116936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tbx1 and Foxi3 genetically interact in the pharyngeal pouch endoderm in a mouse model for 22q11.2 deletion syndrome.
    Hasten E; Morrow BE
    PLoS Genet; 2019 Aug; 15(8):e1008301. PubMed ID: 31412026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage.
    Liao J; Kochilas L; Nowotschin S; Arnold JS; Aggarwal VS; Epstein JA; Brown MC; Adams J; Morrow BE
    Hum Mol Genet; 2004 Aug; 13(15):1577-85. PubMed ID: 15190012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
    Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
    Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chordin is a modifier of tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse.
    Choi M; Klingensmith J
    PLoS Genet; 2009 Feb; 5(2):e1000395. PubMed ID: 19247433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene.
    Chieffo C; Garvey N; Gong W; Roe B; Zhang G; Silver L; Emanuel BS; Budarf ML
    Genomics; 1997 Aug; 43(3):267-77. PubMed ID: 9268629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left pulmonary artery in 22q11.2 deletion syndrome. Echocardiographic evaluation in patients without cardiac defects and role of Tbx1 in mice.
    Mastromoro G; Calcagni G; Versacci P; Putotto C; Chinali M; Lambiase C; Unolt M; Pelliccione E; Anaclerio S; Caprio C; Cioffi S; Bilio M; Baban A; Drago F; Digilio MC; Marino B; Baldini A
    PLoS One; 2019; 14(4):e0211170. PubMed ID: 30933971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1.
    Papangeli I; Scambler P
    Wiley Interdiscip Rev Dev Biol; 2013; 2(3):393-403. PubMed ID: 23799583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.
    Zweier C; Sticht H; Aydin-Yaylagül I; Campbell CE; Rauch A
    Am J Hum Genet; 2007 Mar; 80(3):510-7. PubMed ID: 17273972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome.
    Racedo SE; Hasten E; Lin M; Devakanmalai GS; Guo T; Ozbudak EM; Cai CL; Zheng D; Morrow BE
    PLoS Genet; 2017 Mar; 13(3):e1006687. PubMed ID: 28346476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
    Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
    Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ripply3, a Tbx1 repressor, is required for development of the pharyngeal apparatus and its derivatives in mice.
    Okubo T; Kawamura A; Takahashi J; Yagi H; Morishima M; Matsuoka R; Takada S
    Development; 2011 Jan; 138(2):339-48. PubMed ID: 21177346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome.
    Heike CL; Starr JR; Rieder MJ; Cunningham ML; Edwards KL; Stanaway IB; Crawford DC
    Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):54-63. PubMed ID: 19645056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.